MEDICINOVA, INC. Preferred Stock, Accretion of Redemption Discount
MEDICINOVA, INC. (MNOV) reported Preferred Stock, Accretion of Redemption Discount of $98.44 thousand for the 156-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Shareholders' Equity
us-gaap:PreferredStockAccretionOfRedemptionDiscount · last filed 2013-11-07
- MEDICINOVA, INC. preferred stock, accretion of redemption discount for the quarter ending 2013-09-30 was $0.00.
- MEDICINOVA, INC. preferred stock, accretion of redemption discount for the quarter ending 2013-06-30 was $0.00.
- MEDICINOVA, INC. preferred stock, accretion of redemption discount for the quarter ending 2013-03-31 was $0.00.
- MEDICINOVA, INC. preferred stock, accretion of redemption discount for the quarter ending 2012-09-30 was $0.00.
- MEDICINOVA, INC. preferred stock, accretion of redemption discount for fiscal 2005 was $19.69K, a 75.00% decline from fiscal 2004.
- MEDICINOVA, INC. preferred stock, accretion of redemption discount for fiscal 2004 was $78.76K.
| Period end | Preferred Stock, Accretion of Redemption Discount 3 month | Preferred Stock, Accretion of Redemption Discount 6 month | Preferred Stock, Accretion of Redemption Discount 9 month | Preferred Stock, Accretion of Redemption Discount 12 month | Preferred Stock, Accretion of Redemption Discount 12 month as first filed | Preferred Stock, Accretion of Redemption Discount 129 month | Preferred Stock, Accretion of Redemption Discount 132 month | Preferred Stock, Accretion of Redemption Discount 135 month | Preferred Stock, Accretion of Redemption Discount 138 month | Preferred Stock, Accretion of Redemption Discount 141 month | Preferred Stock, Accretion of Redemption Discount 144 month | Preferred Stock, Accretion of Redemption Discount 147 month | Preferred Stock, Accretion of Redemption Discount 150 month | Preferred Stock, Accretion of Redemption Discount 153 month | Preferred Stock, Accretion of Redemption Discount 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 156 month − 10-Q 153 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 derived: sum of 3 quarters · filed 2013-11-07 | $98.44K 10-Q · filed 2013-11-07 | |||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 153 month − 10-Q 150 month · filed 2013-08-08 | $0.00 derived: sum of 2 quarters · filed 2013-08-08 | $98.44K 10-Q · filed 2013-08-08 | ||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 150 month − 10-K 147 month · filed 2013-05-08 | $98.44K 10-Q · filed 2013-05-08 | |||||||||||||
| 2012-12-31 | $98.44K 10-K · filed 2013-03-28 | ||||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 144 month − 10-Q 141 month · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 derived: sum of 3 quarters · filed 2012-11-08 | $0.00 derived: sum of 4 quarters · filed 2012-11-08 | $98.44K 10-Q · filed 2012-11-08 | ||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 141 month − 10-Q 138 month · filed 2012-08-09 | $0.00 derived: sum of 2 quarters · filed 2012-08-09 | $0.00 derived: sum of 3 quarters · filed 2012-08-09 | $0.00 derived: sum of 4 quarters · filed 2012-08-09 | $98.44K 10-Q · filed 2012-08-09 | ||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 138 month − 10-K 135 month · filed 2012-05-10 | $0.00 derived: sum of 2 quarters · filed 2012-05-10 | $0.00 derived: sum of 3 quarters · filed 2012-05-10 | $0.00 derived: sum of 4 quarters · filed 2012-05-10 | $98.44K 10-Q · filed 2012-05-10 | ||||||||||
| 2011-12-31 | $0.00 derived: 10-K 135 month − 10-Q 132 month · filed 2012-03-29 | $0.00 derived: sum of 2 quarters · filed 2012-03-29 | $0.00 derived: sum of 3 quarters · filed 2012-03-29 | $98.44K 10-K · filed 2012-03-29 | |||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 | $0.00 derived: sum of 2 quarters · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | $98.44K 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 | $0.00 10-Q · filed 2011-08-15 | $98.44K 10-Q · filed 2011-08-15 | ||||||||||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 | $0.00 derived: sum of 2 quarters · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 | $0.00 10-Q · filed 2011-08-15 | |||||||||||||
| 2005-12-31 | $19.69K 10-K · filed 2013-03-28 | -$19.69K 10-K · filed 2012-03-29 | |||||||||||||
| 2004-12-31 | $78.76K 10-K · filed 2013-03-28 | -$78.76K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |